Progress Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
- Revenue Growth 13943.69%
- Profit Growth 20948.03%
- Ebitda 35715.54%
- Net Worth 14575.03%
- Total Assets 10953.38%
About Progress Life Sciences
Progress Life Sciences Private Limited (PLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 September 2014 and has a history of Ten years and five months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹2.65 Cr.
Ashutosh Pandey, Balasaheb Nikam, and Laxman Nikam serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2014PTC257867
- Company No.
257867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Progress Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashutosh Pandey  | Director | 25-Jul-2023 | Current |
| Balasaheb Nikam | Director | 08-Sep-2014 | Current |
| Laxman Nikam | Director | Current |
Financial Performance of Progress Life Sciences.
Progress Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13943.69% increase. The company also saw a substantial improvement in profitability, with a 20948.03% increase in profit. The company's net worth Soared by an impressive increase of 14575.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Progress Life Sciences?
In 2023, Progress Life Sciences had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Progress-Biosciences Private LimitedAshutosh Pandey and Balasaheb Nikam are mutual person
- Atomix Engineering Private Limited
Ashutosh Pandey and Balasaheb Nikam are mutual person
Charges (Loans)
Open Charges
₹26.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2022 | Axis Bank Limited | ₹4.00 M | Open |
| 18 Feb 2022 | Axis Bank Limited | ₹2.25 Cr | Open |
How Many Employees Work at Progress Life Sciences?
Progress Life Sciences has a workforce of 16 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Progress Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Progress Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Progress Life Sciences
Recent activity within the organization
- Charges
A charge with Axis Bank Limited of Rs. 22.50 M registered on 18 Feb 2022 with Charge ID 100542377 was modified on 16 Dec 2023.
16 Dec 2023
- Annual General Meeting
Progress Life Sciences Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023
- Director Appointment
Ashutosh Kedarnath Pandey was appointed as a Director was appointed as a Director on 25 Jul 2023 & has been associated with this company since 1 year 7 months .
25 Jul 2023
- Balance Sheet
Progress Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023
- Charges
A charge with Axis Bank Limited amounted to Rs. 4.00 M with Charge ID 100606619 was registered on 21 Jul 2022.
21 Jul 2022
- Charges
A charge with Axis Bank Limited amounted to Rs. 22.50 M with Charge ID 100542377 was registered on 18 Feb 2022.
18 Feb 2022
Frequently asked questions
What is the Incorporation or founding date of Progress Life Sciences Private Limited?
Progress Life Sciences Private Limited was incorporated on 08 Sep 2014.
What is authorized share capital and paid-up capital of Progress Life Sciences Private Limited?
The authorized share capital of Progress Life Sciences Private Limited is ₹ 3.00 M and paid-up capital is ₹ 0.11 M.
Who are the current board members & directors of Progress Life Sciences Private Limited?
Currently 3 directors are associated with Progress Life Sciences Private Limited.
- Ashutosh Kedarnath Pandey
- Balasaheb Laxman Nikam
- Laxman Dagadu Nikam
What is the registered address of Progress Life Sciences Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Progress Life Sciences Private Limited is Plot No.17 And 18 Office No. 225 Platinum Techno Park Sector 30A Vashi, India, Navi Mumbai, Maharashtra, 400703.
What is the corporate identification number (CIN) and company number of Progress Life Sciences Private Limited?
The corporate identification number (CIN) of Progress Life Sciences Private Limited is U74999MH2014PTC257867 and the company number is 257867 as per Ministry of Corporate Affairs (MCA).
What is the official website of Progress Life Sciences Private Limited?
The Official website of Progress Life Sciences Private Limited is https://www.progresslifesciences.com
What has been the recent revenue trend for Progress Life Sciences Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Progress Life Sciences Private Limited has risen by 13943.69%.
How many employees does Progress Life Sciences Private Limited currently have?
As Per 2023 financial reports, 16 employees are currently employed by Progress Life Sciences Private Limited.
What change has been observed in the net worth of Progress Life Sciences Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Progress Life Sciences Private Limited has experienced an upsurge of 14575.03%.
What are the total open charges for Progress Life Sciences Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Progress Life Sciences Private Limited amount to ₹ 2.65 Cr.
When was the last Balance Sheet of Progress Life Sciences Private Limited filed with the ROC?
The most recent Balance Sheet for Progress Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.